Demographics
| No. registered/evaluable . | 34/32 . |
|---|---|
| Age, median (range) | 64 (42–81) |
| Gender | |
| Male | 28 |
| Female | 6 |
| Race | |
| Caucasian | 33 |
| African-American | 1 |
| ECOG performance score | |
| 0 | 16 |
| 1 | 18 |
| Previous biologic response modifiers | 1 |
| Previous nephrectomy | 24 |
| LDHa >1.5 × normal | 3 |
| Time from diagnosis <1 year | 17 |
| Hemoglobin less than lower limit of normal | 21 |
| Corrected serum calcium greater than normal | 2 |
| Tumor sites | |
| Lung | 23 |
| Mediastinum | 3 |
| Lymph nodes | 14 |
| Bone | 8 |
| Liver | 6 |
| Kidney | 10 |
| No. adverse prognostic factors21,29 | |
| 0 (Good) | 6 |
| 1–2 (Intermediate) | 19 |
| ≥3 (Poor) | 7 |
| No. registered/evaluable . | 34/32 . |
|---|---|
| Age, median (range) | 64 (42–81) |
| Gender | |
| Male | 28 |
| Female | 6 |
| Race | |
| Caucasian | 33 |
| African-American | 1 |
| ECOG performance score | |
| 0 | 16 |
| 1 | 18 |
| Previous biologic response modifiers | 1 |
| Previous nephrectomy | 24 |
| LDHa >1.5 × normal | 3 |
| Time from diagnosis <1 year | 17 |
| Hemoglobin less than lower limit of normal | 21 |
| Corrected serum calcium greater than normal | 2 |
| Tumor sites | |
| Lung | 23 |
| Mediastinum | 3 |
| Lymph nodes | 14 |
| Bone | 8 |
| Liver | 6 |
| Kidney | 10 |
| No. adverse prognostic factors21,29 | |
| 0 (Good) | 6 |
| 1–2 (Intermediate) | 19 |
| ≥3 (Poor) | 7 |
LDH, lactate dehydrogenase.